Tech Company Financing Transactions
Altesa BioSciences Funding Round
Altesa BioSciences secured a $75 million Series B funding round on 2/19/2026. Investors included Forbion Capital Partners, Atlantic Capital Partners and Medicxi Ventures.
Transaction Overview
Company Name
Announced On
2/19/2026
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support the CARDINAL study, a Phase 2b multinational randomized placebo-controlled trial that will enroll 900 COPD patients in the US and UK, following them and randomizing when they experience a rhinovirus infection.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1930 Harvard Avenue
College Park, GA 30337
USA
College Park, GA 30337
USA
Phone
Website
Email Address
Overview
Altesa is an innovative, clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases, including COPD and asthma, from the threat of severe viral respiratory infections. Our primary focus is rhinovirus, the most common respiratory virus on the planet and the main cause of serious, potentially life-threatening exacerbations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Moncef Slaoui
Chief Executive Officer
Brett Giroir
Chief Financial Officer
Andy Drechsler
Chief Medical Officer
Kate Knobil
Chief Operating Officer
John Clerici
Vice President
Katherine Squires
VP - Bus. Development
Karen Fusaro
VP - Human Resources
Erica Bitten
VP - Manufacturing
Alan Parr
VP - Operations
Melissa Allaband
VP - Regulatory Affairs
Katie Laessig
VP - Regulatory Affairs
Laura Smart
Browse more venture capital transactions:
Prev: 2/19/2026: ElevenEs venture capital transaction
Next: 2/19/2026: Kiavi venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs